OKLAHOMA CITY -- CVS-Caremark (CVS) is introducing next month a "health savings pass" that promises cut-rate prices on hundreds of generic drugs used to treat common conditions such as diabetes and high blood pressure.
After purchasing the $10 pass, CVS customers will pay just $9.99 -- a penny less than they would at Wal-Mart (WMT) -- for a 90-day supply of 400 different generic maintenance drugs.
With that same card, cash-paying customers can also receive a 10% discount for treatment provided by the company's in-store MinuteClinics.
"People are struggling with health care costs, especially the uninsured and the underinsured," CVS CEO Tom Ryan stated when introducing the new program on Thursday. "As the largest provider of pharmacy health care in the nation, we felt it was the right time to offer consumers another way to make their health care more affordable."This new program will not only provide affordability and convenience," Ryan continued, "but also the superior service and execution that consumers have come to expect from CVS." CVS could pay a price, however. While the new savings program might attract more shoppers to its stores -- including some who now buy cheap generics at Wal-Mart or Target (TGT) -- it will threaten a key source of profits in the process. Right now, CVS can often make more money marking up a cheap generic drug than it can by selling its expensive brand-name counterpart. For the drugs covered under its new savings card, however, that dependable margin-booster will shrink or disappear.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV